21 – 30 of 58
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
A major population of mucosal memory CD4(+) T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.
(
- Contribution to journal › Article
- 2014
-
Mark
Infiltration of CD3(+) and CD68(+) cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
(
- Contribution to journal › Article
- 2013
-
Mark
Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol
(
- Contribution to journal › Article
-
Mark
IRF4 Transcription-Factor-Dependent CD103(+)CD11b(+) Dendritic Cells Drive Mucosal T Helper 17 Cell Differentiation.
(
- Contribution to journal › Article
-
Mark
Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6C(hi) monocyte precursors
(
- Contribution to journal › Article
-
Mark
Toward a Molecular Pathologic Classification of Urothelial Carcinoma.
(
- Contribution to journal › Article
-
Mark
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
(
- Contribution to journal › Scientific review
-
Mark
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary Diversion
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.
(
- Contribution to journal › Article